... information please contact [email protected]. Abstract The annual Medicare Trustees Report projects when the Hospital Insurance Trust Fund will become insolvent, a key indicator of the Medicare program’s fiscal health. Over the past 40 years, the Trust Fund insolvency date was extended 20 times...

... (Aduhelm; Biogen), a first-in-class monoclonal antibody (mAb) for treatment of AD. In July 2021, responding to the significant controversy sparked by aducanumab’s approval, the Centers for Medicare and Medicaid Services (CMS) opened a National Coverage Determination (NCD) analysis for mAbs intended...

... of interest: J.Y. reported receiving grants from the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and Patient-Centered Outcomes Research Institute, outside the submitted work. L.P.C. reported being a paid member of the Medicare Payment Advisory Commission outside...

... is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights ) Medicare Opioid use disorder Social vulnerability US counties The prevalence of older Medicare beneficiaries (aged 65...

... and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Abstract Under the Inflation Reduction Act's (IRA's) - Medicare Drug Price...

..., and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Notes 1 Centers for Medicare and Medicaid Services . Oncology Care Model. Accessed September 5, 2023. https://www.cms.gov/priorities/innovation/innovation-models/oncology...

..., distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction Medicare beneficiaries face significant health risks and care disruptions during public health emergencies, but little is known about how care patterns evolved throughout the COVID-19 pandemic...

..., multiple insulin-related policies took effect for Medicare Part D plans, including the Part D Senior Savings Model test (2021–2023) and the 2022 Inflation Reduction Act, provisions of which were implemented between 2023 and 2025. These policies created a variety of financial incentives for plans that may...

... information please contact [email protected]. Abstract Background and Objectives Medicare-funded Home Health (HH) delivers skilled care via visits to patients’ homes. Social work (SW) services are included within the HH benefit and may positively impact outcomes for HH patients with complex...

...-NR012459 NIA 10.13039/100000049 U01 AG32947 Dementia affects approximately 10% of U.S. older adults ( 1 ) with an estimated financial burden similar to that of heart disease and cancer ( 2 ). It has been estimated that Medicare will spend $164 billion in 2024 on the treatment and management...

... for medicare and medicaid on index date  No Referent  Yes 1.49 ( 1.02-2.17) Eligible for medicare part D low-income subsidy on index date  No Referent  Yes 1.53 (0.95-2.46) Urbanicity  Metropolitan (urban) Referent  Nonmetropolitan, adjacent to metro 0.83 (0.63-1.10...

... or five different portals. HHA 6 HHA reports using lots of portals; and if not portals, waiting on phone There's all kinds of portals that you can go into. Each Medicare Advantage plan will have their own portals. Or those that don’t, you have to call up on the phone and sit there sometimes two hours...

...). The occurrence of these events was coded categorically: 0 hospitalization or at least 1 hospitalization. We defined hospitalization as any record in the Centers for Medicare and Medicaid Services (CMS) inpatient claims file with a length of stay of more than 1 day in 2018. ACSCs are conditions leading...

... from Teladoc, Koneksa Health, and ASH Research Collaborative. S.B.D. reports funding from Arnold Ventures and the Commonwealth Fund and is a member of the Institute for Clinical and Economic Review's (ICER) Midwestern Comparative Effectiveness Advisory Council and a member of the Medicare Payment...

... month and year of death on most decedents who had not dropped out of the study. Because losses to follow-up are not insubstantial, ascertainment of mortality is likely incomplete. Methods We used linked Medicare data as the reference standard to determine the extent by which mortality...

... in MA. ¹⁹ We also focused on a study sample of patients originally eligible for Medicare based on age (not disability), who did not have end-stage renal disease (ESRD), and who were not in long-term institutional care. We focused on these patients because it is a more homogenous sample. We...

... for Medicare & Medicaid Services . Medicare program; payments for new medical services and new technologies under the acute care hospital inpatient prospective payment system . Federal Register . September 2001 . 2 Centers for Medicare & Medicaid Services . New medical services and new...

... conditions Methods Our data source was a random sample of Medicare administrative claims for years 2016-2019. Inclusion criteria included age > 65 years and new diagnosis of OSA. Exclusion criteria included evidence of prior OSA treatment during the 12 months prior to the index date, active cancer...

... litigation and suggests litigation reforms to expedite biosimilar market availability. patents medicare biologic biosimilar drug spending Arnold Ventures 10.13039/100014848 From 2015 to 2021 there were only 11 biosimilars marketed in the US. In contrast, from 2008 to 2021, there were 55 biosimilars...

... than one hospital or clinic participating in the program. We use Medicare Part D data from 2018 to simulate the proportion of prescription drug fills eligible for 340B discounts and total program spending under both existing and new definitions. We found that the new definition could increase the share...